Abstract
Trans-ancestral variations exist for various anthropometric traits. These traits, including cardiovascular traits, are likely associated with different loci in individuals of different ancestry groups. We assessed the difference in systolic blood pressure, diastolic blood pressure, pulse rate and maximum heart rate among African and European ancestry individuals. Furthermore, we conducted a genome-wide association study of cardiovascular traits in 383,471 Europeans and 5,978 Africans represented in the UK Biobank. Here, we report 2 and 1,202 variants associated with cardiovascular traits in Africans and Europeans, respectively. We identify 2 novel variants in Africans, including rs9388010 located in the GJA1 gene previously associated with numerous cardiomyopathies. Remarkably, we find the associated variants are primarily unique to each ancestry group and map to largely different genes. Through integrative enrichment analyses we find that gene sets within each ancestral group are significantly enriched for pathways and phenotypes related to cardiovascular physiology and disease. Our discoveries provide a better understanding of variations in cardiovascular traits and the different associated variants in Africans and Europeans.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The funding for this project was provided by H3ABioNet, supported by the National Institutes of Health Common Fund under grant number U24HG006941. The content of this publication is solely the authors' responsibility and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study was reviewed by the UK Biobank Project and was exempt from ethical oversight by local legislation. Information on ethics approval by the UK Biobank can be found here: https://www.ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us/ethics#:∼:text=UK%20Biobank%20research%20ethics%20approval%20UK%20Biobank%20has,%28MREC%29%20as%20a%20Research%20Tissue%20Bank%20%28RTB%29%20approval.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
